News › Industry News, Patient Care

Singapore Health Sciences Authority Investigating Case of Blindness after Dermal Filler Treatment

September 15, 2023
Syringes

SINGAPORE: The Health Sciences Authority (HSA) is investigating whether there are problems with a batch of dermal fillers after a woman who was administered with it became blind.

The incident, which occurred in July, is the first local adverse event report for blindness resulting from dermal fillers, HSA said in response to queries from CNA on Tuesday (Sep 12).

Dermal fillers are classified by the HSA as Class D medical devices – the highest risk class.

Read more at Channel News Asia >>

Become a member

Get the tools you need to succeed in the medical spa industry.

Related
    • Medicare GLP-1 Bridge Program Launches July 1, Expanding Access for Some Patients
    • Universal Healthcare Consulting Becomes Platinum Vendor Affiliate with the American Med Spa Association
    • DAW Systems Earns First Artificial Intelligence Accreditation from DirectTrust
    • Estée Lauder Executive’s Death Linked to Pulmonary Embolism Following Cosmetic Filler Injection
    • Allergan Aesthetics Receives Approval for Boey® (trenibotulinumtoxinE) in Canada
Advertisement